BIOCRYST PHARMACEUTICALS INC

Develops oral small-molecule drugs for rare diseases like hereditary angioedema.

BCRX | NDAQ

Overview

Corporate Details

ISIN(s):: US09058V1035
LEI:
Country:: United States of America
Address:: 4505 EMPEROR BOULEVARD, 27703 DURHAM
Website:: https://www.biocryst.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioCryst Pharmaceuticals Inc. is a commercial-stage biotechnology company focused on the discovery, development, and commercialization of novel medicines for rare diseases. The company specializes in creating oral small-molecule and protein therapeutics for patients with significant unmet medical needs, with a primary focus on hereditary angioedema (HAE) and other complement-mediated conditions. Founded in 1986, BioCryst utilizes a structure-guided drug design approach that combines biology, chemistry, and advanced technologies to develop first-in-class or best-in-class treatments. The company's mission is to improve patients' lives by advancing novel therapeutics globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOCRYST PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOCRYST PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BIOCRYST PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CTC BIO, INC. Develops pharmaceuticals and feed additives for human and animal health using fermentation tech.	South Korea	060590
Cue Biopharma, Inc. Develops injectable biologics to selectively activate T cells for oncology & autoimmune disease.	United States of America	CUE
Cullinan Therapeutics, Inc. Developing differentiated immune-modulating therapies for cancer and autoimmune diseases.	United States of America	CGEM
CUMBERLAND PHARMACEUTICALS INC Acquires and commercializes branded medicines for acute care, gastroenterology, and oncology.	United States of America	CPIX
Cuorips Inc. Develops iPS cell therapies, like a cardiomyocyte sheet for severe heart failure.	Japan	4894
Cuprina Holdings (Cayman) LTD Biomedical firm specializing in Maggot Debridement Therapy for wound care in Singapore & Hong Kong.	United States of America	CUPR
curacle co., ltd. Developing drugs for intractable diseases like diabetes caused by vascular damage and aging.	South Korea	365270
Curanex Pharmaceuticals Inc Developing botanical drugs for inflammatory diseases, diabetes, and COVID-19.	United States of America	CURX
Curevac Pioneering mRNA technology to create vaccines and therapies for infectious diseases, cancer, and more.	Germany	CVAC
CureVac N.V. Pioneering mRNA technology for prophylactic vaccines and novel cancer immunotherapies.	United States of America	CVAC